CDKN2B and urinary bladder cancer: For example, CDKN2B‐AS1 was reported to promote proliferation and inhibit apoptosis in hepatocellular carcinoma,9 non‐small cell lung cancer,10 and bladder cancer.12 It is a common strategy to kill cancer by suppressing cancer cell proliferation and inducing apoptosis.